Delivery of a clinical genomics service

Genes

Volumn 5, Issue 4, 2014, Pages 1001-1017

  Newman, William G ^a,b   Black, Graeme C ^a,b  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MANCHESTER UNIVERSITY NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Exome; Next generation sequencing; Panel testing; Rare disease

Indexed keywords

CLINICAL EXOME SEQUENCING; CLINICAL GENETICS; CLINICAL PRACTICE; COPY NUMBER VARIATION; EXOME; GENE MUTATION; GENETIC PREDISPOSITION; GENETIC PROCEDURES; GENETIC VARIABILITY; GENOME ANALYSIS; HEALTH CARE ACCESS; HEALTH CARE COST; HEALTH CARE DELIVERY; HUMAN; MEDICAL EDUCATION; MEDICAL ETHICS; MOLECULAR DIAGNOSIS; MOLECULAR GENETICS; NEWBORN SCREENING; NEXT GENERATION SEQUENCING; OUTCOME ASSESSMENT; PERSONALIZED MEDICINE; PHARMACOGENETICS; PHENOTYPE; POLYMERASE CHAIN REACTION; RARE DISEASE; REVIEW; RISK BENEFIT ANALYSIS; SEQUENCE ANALYSIS; TANDEM MASS SPECTROMETRY; WHOLE EXOME SEQUENCING; WHOLE GENOME SEQUENCING;

EID: 84908702554     PISSN: None     EISSN: 20734425     Source Type: Journal    
DOI: 10.3390/genes5041001     Document Type: Review

References (39)

1. Chief Medical Officer. Rare is common. In Chief Medical Officer. Annual Report of the Chief Medical Officer 2009; Department of Health: London, UK, 2009; pp. 38-45.
2. National Institutes of Health. Office of Rare Disease Research (ORDR). Available online: http://rarediseases.info.nih.gov/AboutUs.aspx (accessed on 10 August 2014).
3. Genetic Testing Registry (GTR). Available online: http://www.ncbi.nlm.nih.gov/gtr/ (accessed on 10 August 2014).
4. Macpherson, J.; Sawyer, H. Best practice guidelines for molecular diagnosis of Fragile X Syndrome. Available online: http://www.acgs.uk.com/quality-committee/best-practice-guidelines/ (accessed on 10 August 2014).
5. Yang, Y.; Muzny, D.M.; Reid, J.G.; Bainbridge, M.N.; Willis, A.; Ward, P.A.; Braxton, A.; Beuten, J.; Xia, F.; Niu, Z., et al. Clinical whole-exome sequencing for the diagnosis of mendelian disorders. N. Engl. J. Med. 2013, 369, 1502-1511.
6. Ng, S.B.; Turner, E.H.; Robertson, P.D.; Flygare, S.D.; Bigham, A.W.; Lee, C.; Shaffer, T.; Wong, M.; Bhattacharjee, A.; Eichler, E.E., et al. Targeted capture and massively parallel sequencing of 12 human exomes. Nature 2009, 461, 272-276.
7. Ng, S.B.; Buckingham, K.J.; Lee, C.; Bigham, A.W.; Tabor, H.K.; Dent, K.M.; Huff, C.D.; Shannon, P.T.; Jabs, E.W.; Nickerson, D.A., et al. Exome sequencing identifies the cause of a mendelian disorder. Nat. Genet. 2010, 42, 30-35.
8. Biesecker, L.G. Exome sequencing makes medical genomics a reality. Nat. Genet. 2010, 42, 13-14.
9. Rehm, H.L. Disease-targeted sequencing: A cornerstone in the clinic. Nat. Rev. Genet. 2013, 14, 295-300.
10. O’Sullivan, J.; Mullaney, B.G.; Bhaskar, S.S.; Dickerson, J.E.; Hall, G.; O’Grady, A.; Webster, A.; Ramsden, S.C.; Black, G.C. A paradigm shift in the delivery of services for diagnosis of inherited retinal disease. J. Med. Genet. 2012, 49, 322-326.
11. Gilissen, C.; Hoischen, A.; Brunner, H.G.; Veltman, J.A. Disease gene identification strategies for exome sequencing. Eur. J. Hum. Genet. 2012, 20, 490-497.
12. Braun, T.A.; Mullins, R.F.; Wagner, A.H.; Andorf, J.L.; Johnston, R.M.; Bakall, B.B.; Deluca, A.P.; Fishman, G.A.; Lam, B.L.; Weleber, R.G., et al. Non-exomic and synonymous variants in ABCA4 are an important cause of Stargardt disease. Hum. Mol. Genet. 2013, 22, 5136-5145.
13. Harismendy, O.; Ng, P.C.; Strausberg, R.L.; Wang, X.; Stockwell, T.B.; Beeson, K.Y.; Schork, N.J.; Murray, S.S.; Topol, E.J.; Levy, S., et al. Evaluation of next generation sequencing platforms for population targeted sequencing studies. Genome Biol. 2009, 10, doi:10.1186/gb-2009-10-3-r32.
14. Gillespie, R.L.; O’Sullivan, J.; Ashworth, J.; Bhaskar, S.; Williams, S.; Biswas, S.; Kehdi, E.; Ramsden, S.C.; Clayton-Smith, J.; Black, G.C., et al. Personalized diagnosis and management of congenital cataract by next-generation sequencing. Ophthalmology 2014, doi:10.1016/j.ophtha.2014.06.006.
15. Kocarnik, J.M.; Fullerton, S.M. Returning pleiotropic results from genetic testing to patients and research participants. JAMA 2014, 311, 795-796.
16. Black, G.C. University of Manchester, Manchester, UK. Personal Communication, 2014.
17. Clarke, A.J. Managing the ethical challenges of next-generation sequencing in genomic medicine. Br. Med. Bull. 2014, 111, 17-30.
18. Jones, M.A.; Rhodenizer, D.; da Silva, C.; Huff, I.J.; Keong, L.; Bean, L.J.; Coffee, B.; Collins, C.; Tanner, A.K.; He, M., et al. Molecular diagnostic testing for congenital disorders of glycosylation (CDG): Detection rate for single gene testing and next generation sequencing panel testing. Mol. Genet. Metab. 2013, 110, 78-85.
19. Manyika, J.; Chui, M.; Bughin, J.; Dobbs, R.; Bisson, P.; Marrs, A. Disruptive technologies: Advances that will transform life, business, and the global economy. McKinsey Global Institute, 2013. Available online: http://www.mckinsey.com/insights/business_technology/disruptive_technologies (accessed on 10 August 2014).
20. Jacob, H.J. Next-generation sequencing for clinical diagnostics. N. Engl. J. Med. 2013, 369, 1557-1558.
21. Saunders, C.J.; Miller, N.A.; Soden, S.E.; Dinwiddie, D.L.; Noll, A.; Alnadi, N.A.; Andraws, N.; Patterson, M.L.; Krivohlavek, L.A.; Fellis, J., et al. Rapid whole-genome sequencing for genetic disease diagnosis in neonatal intensive care units. Sci. Transl. Med. 2012, 4, doi:10.1126/scitranslmed.3004041.
22. Dixon-Salazar, T.J.; Silhavy, J.L.; Udpa, N.; Schroth, J.; Bielas, S.; Schaffer, A.E.; Olvera, J.; Bafna, V.; Zaki, M.S.; Abdel-Salam, G.H., et al. Exome sequencing can improve diagnosis and alter patient management. Sci. Transl. Med. 2012, 4, doi:10.1126/scitranslmed.3003544.
23. Worthey, E.A.; Mayer, A.N.; Syverson, G.D.; Helbling, D.; Bonacci, B.B.; Decker, B.; Serpe, J.M.; Dasu, T.; Tschannen, M.R.; Veith, R.L., et al. Making a definitive diagnosis: Successful clinical application of whole exome sequencing in a child with intractable inflammatory bowel disease. Genet. Med. 2011, 13, 255-262.
24. Bainbridge, M.N.; Wiszniewski, W.; Murdock, D.R.; Friedman, J.; Gonzaga-Jauregui, C.; Newsham, I.; Reid, J.G.; Fink, J.K.; Morgan, M.B.; Gingras, M.C., et al. Whole-genome sequencing for optimized patient management. Sci. Transl. Med. 2011, 3, doi:10.1126/scitranslmed.3002243.
25. Lupski, J.R.; Reid, J.G.; Gonzaga-Jauregui, C.; Rio Deiros, D.; Chen, D.C.; Nazareth, L.; Bainbridge, M.; Dinh, H.; Jing, C.; Wheeler, D.A., et al. Whole-genome sequencing in a patient with Charcot-Marie-Tooth neuropathy. N. Engl. J. Med. 2010, 362, 1181-1191.
26. Onoufriadis, A.; Shoemark, A.; Munye, M.M.; James, C.T.; Schmidts, M.; Patel, M.; Rosser, E.M.; Bacchelli, C.; Beales, P.L.; Scambler, P.J., et al. Combined exome and whole-genome sequencing identifies mutations in ARMC4 as a cause of primary ciliary dyskinesia with defects in the outer dynein arm. J. Med. Genet. 2014, 51, 61-67.
27. Weedon, M.N.; Cebola, I.; Patch, A.M.; Flanagan, S.E.; de Franco, E.; Caswell, R.; Rodríguez-Seguí, S.A.; Shaw-Smith, C.; Cho, C.H.; Lango A.H., et al. Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat. Genet. 2014, 46, 61-64.
28. Gilissen, C.; Hehir-Kwa, J.Y.; Thung, D.T.; van de Vorst, M.; van Bon, B.W.; Willemsen, M.H.; Kwint, M.; Janssen, I.M.; Hoischen, A.; Schenck, A., et al. Genome sequencing identifies major causes of severe intellectual disability. Nature 2014, 511, 344-347.
29. Exome Variant Server, NHLBI GO Exome Sequencing Project (ESP). Available online: http://evs.gs.washington.edu/EVS/ (accessed on 10 August 2014).
30. Gottlieb, B.; Beitel, L.K.; Trifiro, M. Changing genetic paradigms: Creating next-generation genetic databases as tools to understand the emerging complexities of genotype/phenotype relationships. Hum. Genomics 2014, 8, doi:10.1186/1479-7364-8-9.
31. Veltman, J.A.; Brunner, H.G. De novo mutations in human genetic disease. Nat. Rev. Genet. 2012, 13, 565-575.
32. Raychaudhuri, S.; Iartchouk, O.; Chin, K.; Tan, P.L.; Tai, A.K.; Ripke, S.; Gowrisankar, S.; Vemuri, S.; Montgomery, K.; Yu, Y., et al. A rare penetrant mutation in CFH confers high risk of age-related macular degeneration. Nat. Genet. 2011, 43, 1232-1236.
33. Torjesen, I. Genomes of 100,000 people will be sequenced to create an open access research resource. Br. Med. J. 2013, 347, doi:10.1136/bmj.f6690.
34. Köhler, S.; Doelken, S.C.; Mungall, C.J.; Bauer, S.; Firth, H.V.; Bailleul-Forestier, I.; Black, G.C.; Brown, D.L.; Brudno, M.; Campbell, J., et al. The Human Phenotype Ontology project: Linking molecular biology and disease through phenotype data. Nucleic Acids Res. 2014, 42, D966-D974.
35. Green, R.C.; Berg, J.S.; Grody, W.W.; Kalia, S.S.; Korf, B.R.; Martin, C.L.; McGuire, A.L.; Nussbaum, R.L.; O’Daniel, J.M.; Ormond, K.E., et al. ACMG recommendations for reporting of incidental findings in clinical exome and genome sequencing. Genet. Med. 2013, 15, 565-574.
36. Van El, C.G.; Cornel, M.C.; Borry, P.; Hastings, R.J.; Fellmann, F.; Hodgson, S.V.; Howard, H.C.; Cambon-Thomsen, A.; Knoppers, B.M.; Meijers-Heijboer, H., et al. Whole-genome sequencing in health care: Recommendations of the European Society of Human Genetics. Eur. J. Hum. Genet. 2013, 21, 580-584.
37. Green, R.C.; Lupski, J.R.; Biesecker, L.G. Reporting genomic sequencing results to ordering clinicians: Incidental, but not exceptional. JAMA 2013, 310, 365-366.
38. Levy, H.L.; Shih, V.E.; Madigan, P.M. Routine newborn screening for histidinemia. Clinical and biochemical results. N. Engl. J. Med. 1974, 291, 1214-1219.
39. Payne, K.; McAllister, M.; Davies, L.M. Valuing the economic benefits of complex interventions: When maximising health is not sufficient. Health Econ. 2013, 22, 258-271.